:::

詳目顯示

回上一頁
題名:智能障礙老年人使用抗精神疾病用藥之趨勢分析
書刊名:臺灣老人保健學刊
作者:江博煌董和銳 引用關係張育嘉 引用關係徐尚為 引用關係
作者(外文):Chiang, Po-huangTung, Ho-juiChang, Yu-chiaHsu, Shang-wei
出版日期:2014
卷期:10:2
頁次:頁127-139
主題關鍵詞:抗精神病藥物抗焦慮與鎮靜安眠劑抗憂鬱劑精神興奮藥智能障礙長者AntipsychoticsSedative/anxiolytics and hypnoticsAntidepressantsPsychostimulantsIntellectual disabled elderly
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:27
目的:精神疾病是智能障礙者最常合併症之一,需透過長期藥物來穩定治療,然而國內對其相關研究卻相當缺乏。本研究目的在探討智能障礙老年人使用抗精神疾病用藥之趨勢改變情形。方法:使用1997-2007年全民健康保險資料庫,擷取ICD-9編碼為317-318之智能障礙者編碼,在串聯醫令檔後篩選65歲(含)以上智能障礙長者作為本研究之樣本,探討是否使用抗精神病藥物、抗焦慮與鎮靜安眠劑、抗憂鬱劑與精神興奮藥等藥品與變化趨勢。結果:整體抗精神系統疾病用藥使用盛行率自1997年34.39%逐年增加為2007年的37.05%,11年間上升7.18%(p=0.0036)。除重度重度、極重度個案與投保地為鄉村之個案外,其他變項之變化趨勢均達統計學上之差異。抗焦慮與鎮靜安眠藥之使用逐年遞減;抗精神病藥物、抗憂鬱劑與精神興奮藥之使用率則逐年增加。具精神病診斷而使用抗精神系統疾病用藥之情形亦逐年增加。結論:本研究介紹智能障礙老年人抗精神系統疾病藥使用之變化趨勢,釐清個人基本特質與用藥盛行率趨勢改變之相關性。建議往後研究可以針對長期使用抗精神系統疾病藥對智能障礙者身體健康之影響。
This study aims to examine trends in outpatient psychotropic drug use among elderly people with intellectual disabilities in Taiwan. The NHI outpatient medication records between January 1, 1997 and December 31, 2007 for people age 65 and older with intellectual disabilities were analyzed to observe the percent change, prevalence and prescription trends in psychotropic drugs. The overall prevalence of psychotropic medication increased from 34.39% to 37.05% during the study period. The prescription rates of antipsychotics increased from 24.67% to 38.55% (p<0.001); hypnotics/sedatives decreased from 86.09% to70.00% (p<0.001); antidepressants increased from 24.15% to 43.61% (p<0.001) and psychostimulants increased from19.16 % to 23.25% (p=0.0137). The change of Taiwan's NHI payment policy might have attributed to this trend.
期刊論文
1.嚴嘉楓、林金定(20090600)。智能障礙青少年健康情形與醫療利用及其相關因素之研究。身心障礙研究,7(2),94-120。  延伸查詢new window
2.張剛準、張育嘉、江博煌、徐尚為(20130600)。智能障礙者使用抗精神疾病用藥情形之分析。身心障礙研究,11(2),85-100。  延伸查詢new window
3.Chang, Y. C.、Lin, J. D.、Tung, H. J.、Chiang, P. H.、Hsu, S. W.(2014)。Outpatient physical therapy utilization for children and adolescents with intellectual disabilities in Taiwan: A population-based nationwide study。Research in Developmental Disabilities,35(2),498-505。  new window
4.Clarke, D. J.、Kelley, S.、Thinn, K.、Corbett, J. A.(1990)。Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings。Journal of Intellectual Disability Research,34(5),385-395。  new window
5.De Kuijper, G.、Hoekstra, P.、Visser, F.、Scholte, F. A.、Penning, C.、Evenhuis, H.(2010)。Use of antipsychotic drugs in individuals with intellectual disability (ID) in the Netherlands: Prevalence and reasons for prescription。Journal of Intellectual Disability Research,54(7),659-667。  new window
6.Doan, T. N.、Lennox, N. G.、Taylor-Gomez, M.、Ware, R. S.(2013)。Medication use among Australian adults with intellectual disability in primary healthcare settings: A cross-sectional study。Journal of Intellectual and Developmental Disability,38(2),177-181。  new window
7.Emerson, E.(2003)。Prevalence of psychiatric disorders in children and adolescents with and without intellectual disability。Journal of Intellectual Disability Research,47(1),51-58。  new window
8.Holden, B.、Gitlesen, J. P.(2004)。Psychotropic medication in adults with mental retardation: prevalence, and prescription practices。Research in Developmental Disabilities,25(6),509-521。  new window
9.Hsu, S. W.、Chiang, P. H.、Chang, Y. C.、Lin, J. D.、Tung, H. J.、Chen, C. Y.(2014)。Trends in the use of psychotropic drugs in people with intellectual disability in Taiwan: A nationwide outpatient service study, 1997-2007。Research in Developmental Disabilities,35(2),364-372。  new window
10.林金定、李佩娜、嚴嘉楓、吳佳玲(20031000)。The Health Status Profile of Persons with Intellectual Disability in Institutions in Taiwan。醫學研究,23(5),285-290。  延伸查詢new window
11.Molteno, G.、Molteno, C. D.、Finchilescu, G.、Dawes, A. R. L.(2001)。Behavioural and emotional problems in children with intellectual disability attending special schools in Cape Town, South Africa。Journal of Intellectual Disability Research,45(6),515-520。  new window
12.Morgan, V. A.、Leonard, H.、Bourke, J.、Jablensky, A.(2008)。Intellectual disability co-occurring with schizophrenia and other psychiatric illness: Population-based study。The British Journal of Psychiatry,193(5),364-372。  new window
13.Tsiouris, J. A.、Kim, S. Y.、Brown, W. T.、Pettinger, J.、Cohen, I. L.(2013)。Prevalence of psychotropic drug use in adults with intellectual disability: Positive and negative findings from a large scale study。Journal of Autism and Developmental Disorders,43(3),719-731。  new window
14.Whitaker, S.、Read, S.(2006)。The prevalence of psychiatric disorders among people with intellectual disabilities: An analysis of the literature。Journal of Applied Research in Intellectual Disabilities,19(4),330-345。  new window
15.Chou, Y. J.、Yip, W. C.、Lee, C. H.、Huang, N.、Sun, Y. P.、Chang, H. J.(2003)。Impact of separating drug prescribing and dispensing on provider behaviour: Taiwan's experience。Health Policy and Planning,18(3),316-329。  new window
16.Deb, S.、Thomas, M.、Bright, C.(2001)。Mental disorder in adults with intellectual disability. 1: Prevalence of functional psychiatric illness among a community-based population aged between 16 and 64 years。Journal of Intellectual Disability Research,45(6),495-505。  new window
17.Lin, J. D.、Yen, C. F.、Li, C. W.、Wu, J. L.(2005)。Health, healthcare utilization and psychiatric disorder in people with intellectual disability in Taiwan。Journal of Intellectual Disability Research,49(1),86-94。  new window
18.嚴嘉楓、林金定、羅慶徽、卓妙如、徐尚為、唐紀絜、吳佳玲(20060300)。機構內智能障礙者合併特殊疾病之健康管理制度分析。身心障礙研究,4(1),1-17。  延伸查詢new window
研究報告
1.林金定、吳佳玲、李志偉、嚴嘉楓、張茂榕、賴朝英(2001)。台灣地區智能障礙者醫療照護政策發展。  延伸查詢new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE